ES532018A0 - A DEVICE TO RELEASE AT A CONTROLLED SPEED A BENEFICIAL AGENT TO A MEDIUM OF USE - Google Patents

A DEVICE TO RELEASE AT A CONTROLLED SPEED A BENEFICIAL AGENT TO A MEDIUM OF USE

Info

Publication number
ES532018A0
ES532018A0 ES532018A ES532018A ES532018A0 ES 532018 A0 ES532018 A0 ES 532018A0 ES 532018 A ES532018 A ES 532018A ES 532018 A ES532018 A ES 532018A ES 532018 A0 ES532018 A0 ES 532018A0
Authority
ES
Spain
Prior art keywords
release
medium
beneficial agent
controlled speed
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES532018A
Other languages
Spanish (es)
Other versions
ES8503503A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES532018(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of ES8503503A1 publication Critical patent/ES8503503A1/en
Publication of ES532018A0 publication Critical patent/ES532018A0/en
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
ES532018A 1983-05-11 1984-04-27 A DEVICE TO RELEASE AT A CONTROLLED SPEED A BENEFICIAL AGENT TO A MEDIUM OF USE Granted ES532018A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11

Publications (2)

Publication Number Publication Date
ES8503503A1 ES8503503A1 (en) 1985-03-01
ES532018A0 true ES532018A0 (en) 1985-03-01

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532018A Granted ES532018A0 (en) 1983-05-11 1984-04-27 A DEVICE TO RELEASE AT A CONTROLLED SPEED A BENEFICIAL AGENT TO A MEDIUM OF USE

Country Status (20)

Country Link
JP (1) JPS6041609A (en)
AT (1) AT397180B (en)
AU (1) AU566110B2 (en)
BE (1) BE898819A (en)
CA (1) CA1222950A (en)
CH (1) CH669329A5 (en)
DE (1) DE3417113A1 (en)
DK (1) DK163910C (en)
ES (1) ES532018A0 (en)
FR (1) FR2545721B1 (en)
GB (1) GB2140687B (en)
IE (1) IE56515B1 (en)
IL (1) IL71727A (en)
IT (1) IT1178911B (en)
MX (1) MX163518B (en)
NL (1) NL192250C (en)
NO (1) NO170834C (en)
NZ (1) NZ206600A (en)
SE (1) SE455918B (en)
ZA (1) ZA842422B (en)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (en) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド Pharmaceutical composition allowing the release of the active ingredient in a controlled manner
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
ES8800043A1 (en) * 1985-08-16 1987-10-16 Alza Corp Osmotic dispenser
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0317780B1 (en) * 1987-11-25 1992-05-20 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
ATE118345T1 (en) * 1990-08-07 1995-03-15 Pfizer USE OF INTERFACIAL POLYMERIZED MEMBRANES IN DELIVERY DEVICES.
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
EP0550641B1 (en) * 1990-09-28 1994-05-25 Pfizer Inc. Dispensing device containing a hydrophobic medium
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
ATE200221T1 (en) * 1993-02-23 2001-04-15 Wolfgang Dr Werner THE USE OF A CALCIUM PREPARATION IN A MEDICATION FOR THE TREATMENT OF DAIRY COWS SUFFERING FROM HYPOCALCEMIA
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (en) 1999-12-24 2001-07-05 Bayer Ag Substituted oxazolidinones and their use
AU2738302A (en) * 2000-10-30 2002-05-15 Euro Celtique Sa Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (en) 2001-06-20 2003-01-02 Bayer Ag Combination therapy of substituted oxazolidinones
DE10300111A1 (en) 2003-01-07 2004-07-15 Bayer Healthcare Ag Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US8163306B2 (en) 2003-09-19 2012-04-24 Sun Pharma Advanced Research Company Oral drug delivery system
DE10355461A1 (en) 2003-11-27 2005-06-23 Bayer Healthcare Ag Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
DE102004062475A1 (en) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Solid, orally administrable, modified release pharmaceutical dosage forms
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005031577A1 (en) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmaceutical dosage forms containing a combination of nifedipine and / or nisoldipine and an angiotensin II antagonist
DE102005045518A1 (en) 2005-09-23 2007-03-29 Bayer Healthcare Ag New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa
CA2624310C (en) 2005-10-04 2014-01-07 Bayer Healthcare Ag Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
DE102005047561A1 (en) 2005-10-04 2007-04-05 Bayer Healthcare Ag Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance
DE102008059206A1 (en) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
US8956654B2 (en) * 2009-06-02 2015-02-17 Dow Global Technologies Llc Sustained release dosage form
DE102011007272A1 (en) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Branched 3-phenylpropionic acid derivatives and their use
IN2014DN09045A (en) 2012-05-07 2015-05-22 Bayer Pharma AG
UY34856A (en) 2012-07-03 2013-12-31 Bayer Pharma AG PHARMACEUTICAL PRESENTATION FORMS CONTAINING 5-CHLORO-N - ({(5S) -2-OXO-3- [4- (3-OXO-4- MORPHOLINYL) -PHENYL] -1,3-OXAZOLIDIN-5-IL} -METIL) -2-THIOFENCARBOXAMIDE
JP5941117B2 (en) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー Sustained release formulation
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form
UY38308A (en) 2018-07-24 2020-02-28 Bayer Pharma AG ORAL ADMINISTRATIVE PHARMACEUTICAL DOSAGE FORM WITH MODIFIED RELEASE
CN112469398A (en) 2018-07-24 2021-03-09 拜耳公司 Pharmaceutical dosage form for oral administration with a sustained release effect

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38538A (en) * 1971-01-13 1974-09-10 Alza Corp Osmotic dispenser
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Also Published As

Publication number Publication date
ATA88084A (en) 1993-07-15
JPS6041609A (en) 1985-03-05
CH669329A5 (en) 1989-03-15
SE8402512L (en) 1984-11-12
NO170834C (en) 1992-12-16
MX163518B (en) 1992-05-25
DE3417113A1 (en) 1984-11-15
ES8503503A1 (en) 1985-03-01
DK99784D0 (en) 1984-02-24
GB2140687B (en) 1987-03-18
NL192250B (en) 1996-12-02
IE840010L (en) 1984-11-11
IT8467283A1 (en) 1985-09-23
SE455918B (en) 1988-08-22
IL71727A0 (en) 1984-09-30
NL8401470A (en) 1984-12-03
IT1178911B (en) 1987-09-16
GB2140687A (en) 1984-12-05
NO840248L (en) 1984-11-12
CA1222950A (en) 1987-06-16
IL71727A (en) 1989-01-31
GB8334189D0 (en) 1984-02-01
AU566110B2 (en) 1987-10-08
NZ206600A (en) 1987-01-23
SE8402512D0 (en) 1984-05-09
AU2251183A (en) 1984-11-15
IT8467283A0 (en) 1984-03-23
DK163910C (en) 1992-09-14
BE898819A (en) 1984-05-30
NO170834B (en) 1992-09-07
ZA842422B (en) 1984-11-28
DE3417113C2 (en) 1989-02-02
JPH0575725B2 (en) 1993-10-21
IE56515B1 (en) 1991-08-28
DK163910B (en) 1992-04-21
FR2545721A1 (en) 1984-11-16
DK99784A (en) 1984-11-12
NL192250C (en) 1997-04-03
AT397180B (en) 1994-02-25
FR2545721B1 (en) 1987-11-06

Similar Documents

Publication Publication Date Title
ES532018A0 (en) A DEVICE TO RELEASE AT A CONTROLLED SPEED A BENEFICIAL AGENT TO A MEDIUM OF USE
ES549639A0 (en) OSMOTIC DEVICE FOR THE CONTROLLED ADMINISTRATION OF A BENEFICIAL AGENT TO A USE ENVIRONMENT
AR240398A1 (en) DEVICE TO MANAGE A BENEFICIAL AGENT TO AN ANIMAL
AR229354A1 (en) PROCEDURE FOR PREPARING A STABILIZED FORMULATION OF IVERMECTIN IN WATER
AR222148A1 (en) A COMPOSITION TO USE IN THE FORMATION OF FRICTION ELEMENTS
BR8603756A (en) DISTRIBUTOR DEVICE FOR THE RELEASE OF A BENEFICIAL AGENT COMPOSITION IN A USE ENVIRONMENT
BR8303523A (en) SANITARY ABSORBENT
AR240399A1 (en) SUPPLY DEVICE TO ADMINISTER A FORMULATION OF BENEFICIAL AGENT TO A USE ENVIRONMENT.
DK113779A (en) ABSORBING DISPOSABLE PILLOW
ES500779A0 (en) A METHOD TO PREPARE A LIQUID AND AQUEOUS COLORING COMPOSITION
FR2416006B1 (en) ABSORBENT TOWEL FOR EXUDATES
ES503119A0 (en) PROCEDURE AND DEVICE FOR THE DISPOSAL OF WATER OVER A PLASTER AND WATER MIXTURE
ES526831A0 (en) PROCEDURE FOR PREPARING A DILUIBLE DISPERSION IN WATER OF POLYMERIC PARTICLES
MX158039A (en) HONEYCOMB IMPROVEMENTS AGAINST INCONTINENCE
FR2522374B1 (en) HYDRAULIC RELEASE STOP
ES556572A0 (en) A DISTRIBUTOR DEVICE TO DOWNLOAD A BENEFICIAL AGENT FORMULATION TO A USE ENVIRONMENT
ES537051A0 (en) PROCEDURE TO PREPARE A COMPOSITION OF ORGANOPOLISILOXANE
ES492908A0 (en) IMPROVEMENTS IN DEVICES TO CLEAN THE CIRCULATORY SPLASHES OF A SOW
ES296272Y (en) DEVICE TO BLOCK A PIPE
MX156975A (en) IMPROVEMENTS IN METHOD TO PREPARE A CATALYST COMPOSITION
ES284622Y (en) DEVICE TO PREPARE AND SUPPLY A SOLUTION.
ES538104A0 (en) AN OSMOTIC SYSTEM FOR THE DOWNLOAD OF A BENEFICIAL AGENT TO A MEDIA OF USE
IT1154378B (en) ANCHORING DEVICE OF SUBMARINE CONDUCTES IN A FIXED SHEATH
DK159991C (en) WORKING CHAIR WITH SWINGABLE GIRL
DK541783A (en) ANTIMYCOTIC AGENT IN THE FORM OF A GEL SYSTEM WITH POWERFUL RELEASE OF ACTIVE SUBSTANCE